Barr J T
Regul Toxicol Pharmacol. 1985 Dec;5(4):432-59. doi: 10.1016/0273-2300(85)90008-x.
Six methods of estimating carcinogenic potency now in use to some extent by regulatory agencies are examined. It is concluded that none of these methods is adequate for regulatory decision making when used alone, as is usually the case, but that all are useful as a contribution to the whole risk assessment process. The needs for further development and improvement of these methods, where appropriate to human risk, are identified and discussed in view of the growing use of potency estimates in regulatory decision making.